Users of the weight loss jab Mounjaro have expressed dismay after manufacturer Eli Lilly announced a price increase in the UK from September. Many fear they will be unable to continue the medication, raising concerns for their mental and physical health.
Trainee driving instructor Michael, 52, from Brighton, said he was 'gutted' by the news. He lost 16kg since April but does not believe the weight will stay off without the drug. 'Paying £330 for Mounjaro is ridiculous,' he said, adding he plans to buy extra needles and guess his dose to stretch supplies.
Polly, a retired NHS worker in her 60s from Cardiff, said Mounjaro 'hugely changed' her life, improving her breathing due to chronic obstructive pulmonary disease. However, the price rise is prohibitive, and she will likely switch to cheaper Wegovy. 'I daren't stop,' she said.
Christopher, 64, a retired solicitor from Ware, Hertfordshire, called the price hike a 'corporate failure'. He pays £205 a month for the maximum dose and has lost 20kg since January. He believes the increase will make it a 'luxury' he cannot afford and may switch to a cheaper alternative.
Some users are wary of switching to Wegovy due to potential side effects and lower effectiveness. The short notice of the price rise has also raised concerns about rapid weight regain for those forced to stop mid-course.
